FilingFirehose · free AI preview
Tango Therapeutics, Inc.
TNGX · AI-generated SEC analysis preview · refreshes when data changes
⚠️ Red flag 8-Ks: 3
Types: Officer Departure
Tango Therapeutics (TNGX) has filed three red-flag 8-Ks in the past 90 days, all related to officer departures—a pattern worth understanding in context. Our 90-day window captures elevated turnover activity, but the full picture requires examination of whether these departures signal strategic shifts, governance concerns, or routine transitions. The full $49 Report adds a dilution risk score, complete 8-K context with filing dates and officer roles, 24-month financing history, and AI-detected risk signals across SEC filings to help you distinguish signal from noise.
Want the full 5-section $49 Report on TNGX?
Dilution risk score · 12 months of 8-K context · financing history · AI risk signals · bottom-line framing. Delivered in ~5 minutes.
See a real sample report →
This preview was AI-generated from FilingFirehose's SEC EDGAR ingestion pipeline.
Not investment advice. Verify all claims against original filings.